Isabelle Leconte
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Pulmonary Hypertension Research and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Hepatology top 1%
- Liver Disease and Transplantation
Papers in
-
- Breast Cancer Treatment Studies 6
-
- Liver Disease and Transplantation 3
- Co-authors
- Sébastiên RouxLewis J. RubinGérald SimonneauNazzareno GalièRobyn J. BarstTomás PulidoMichael J. LandzbergDavid B. Badesch
- Journals
- Journal of Biological Chemistry (3 papers)Reproductive Toxicology (3 papers)Developmental Dynamics (2 papers)European Respiratory Journal (2 papers)Cancers (2 papers)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Isabelle Leconte
52 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Pulmonary and Respiratory Medicine 3.1k
- Hepatology 660
- Cardiology and Cardiovascular Medicine 1.5k
- Genetics 477
- Pathology and Forensic Medicine 537
Countries citing papers authored by Isabelle Leconte
This map shows the geographic impact of Isabelle Leconte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Leconte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Leconte more than expected).
Fields of papers citing papers by Isabelle Leconte
This network shows the impact of papers produced by Isabelle Leconte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Leconte. The network helps show where Isabelle Leconte may publish in the future.
Co-authors
The 25 scholars most cited alongside Isabelle Leconte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 12 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 0 | |
| 5 | 2021 | 4 | |
| 6 | 2019 | 33 | |
| 7 | 2018 | 3 | |
| 8 | 2016 | 14 | |
| 9 | Potential benefits of hypnosis sedation on different modalities of breast cancer treatment | 2014 | 1 |
| 10 | 2012 | 4 | |
| 11 | 2012 | 19 | |
| 12 | BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2011 | 440 |
| 13 | 2010 | 6 | |
| 14 | 2007 | 364 | |
| 15 | 2006 | 3 | |
| 16 | 2001 | 126 | |
| 17 | 2000 | 7 | |
| 18 | 1999 | 14 | |
| 19 | 1998 | 28 | |
| 20 | 1992 | 7 |
About Isabelle Leconte
Isabelle Leconte is a scholar working on Cancer Research, Hepatology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Small Animals, having authored 58 papers that have together received 4.7k indexed citations. Recurring topics across this work include MRI in cancer diagnosis (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Breast Cancer Treatment Studies (6 papers), Pulmonary Hypertension Research and Treatments (6 papers), Breast Lesions and Carcinomas (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Effects and risks of endocrine disrupting chemicals (4 papers) and Liver Disease and Transplantation (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.1k citations), Hepatology (660 citations), Cardiology and Cardiovascular Medicine (1.5k citations), Genetics (477 citations) and Pathology and Forensic Medicine (537 citations). Isabelle Leconte has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Sébastiên Roux, Lewis J. Rubin, Gérald Simonneau, Nazzareno Galiè, Robyn J. Barst, Tomás Pulido, Michael J. Landzberg, David B. Badesch, Adaani Frost and Carol M. Black. Their work appears in journals such as Journal of Biological Chemistry, Reproductive Toxicology, Developmental Dynamics, European Respiratory Journal and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.